Rajnish Mago, MD, Editor-in-Chief .
Rajeev Mahajan, MBBS Executive Editor.
We are grateful to the other members of the Editorial Board for SimpleandPractical.com (listed alphabetically below) who are internationally recognized as leading experts in psychiatry and in psychopharmacology. The Editorial Board monitors our content to avoid any errors and to suggest improvements.
Chittaranjan Andrade, MD
Dr. Andrade has published 19 books, about 40 book chapters, and has authored or coauthored more than 500 scientific papers in peer-reviewed journals.
In addition to being on the Editorial Board of Simple and Practical Mental Health, Dr. Andrade is a member of the editorial boards of:
1. Journal of Clinical Psychiatry
2. International Journal of Bipolar Disorders
3. Bipolar disorders (Field Editor for Clinical Therapeutics)
4. The Journal of ECT
5. Brain Stimulation
6. Indian Journal of Psychiatry.
Leslie Citrome, MD
Dr. Citrome is Clinical Professor of Psychiatry & Behavioral Sciences at New York Medical College in Valhalla, NY, and has a private practice in Pomona, NY.
He completed a Residency and Chief Residency in Psychiatry at the New York University School of Medicine, and went on to complete a Masters in Public Health at Columbia University. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology.He is editor in chief of the International Journal of Clinical Practice and the author/co-author of over 400 published research reports, reviews, and book chapters in the biomedical literature. He is the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.
Jose De Leon, MD
1. Professor of Psychiatry, University of Kentucky College of Medicine, Lexington, Kentucky, USA
2. Director, Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, USA
3. Director, Residency Education, Eastern State Hospital, Lexington, Kentucky, USA
4. Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain
5. Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain
Joseph Goldberg, MD
Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai.
He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 180 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications” published in 2012 by American Psychiatric Publishing. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention.
Heinz C. R. Grunze, MD, PhD
From 2007 to 2015, Dr. Grunze was Professor of Clinical Psychiatry at The Institute of Neuroscience at the University of Newcastle upon Tyne in the United Kingdom. From 2015 to 2016, he was Professor of Psychiatry at the Paracelsius Medical University in Salzburg, Austria where he was the Head of the University Department of Psychiatry. Since January 2017 he is Medical director of the Addiction Services “Evangelische Stadtmission” at Heidelberg, Germany and continues his academic affiliation with the Paracelsius Medical University.
Dr. Grunze’s main research interests include the neurobiology and treatment of bipolar disorder and depression, and the neurobiological effects of antiepileptic drugs and novel antipsychotics. He has received several grants from national and international institutions including a Stanley Foundation International Center Award for clinical studies in bipolar disorder. His research has been published in various internationally-renowned journals.
Dr. Grunze has been very active in the development of International and European practice guidelines. He has been a member of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Bipolar Disorder, the International College of Neuropsychopharmacology (CINP) Task Force on Antidepressant Medication, the International Society for Bipolar Disorders (ISBD) Task Force on Antidepressant Use in Bipolar Disorders.
Gary Sachs, MD
Dr. Gary Sachs is Associate Clinical Professor in Psychiatry at Harvard Medical School and a Clinical Vice President at Bracket.
Dr. Sachs is the Founding Director of the Bipolar Clinic and Research Program at Massachusetts General Hospital (MGH) and founder of the Collaborative Care Initiative.
As Principal Investigator of the National Institute of Mental Health (NIHM) Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), Dr. Sachs led the largest treatment study ever conducted for bipolar disorder.
Dr. Sachs serves on the board of directors for the Depression and Bipolar Support Alliance and Co-chairs the DBSA scientific advisory board. He served on the executive committee of the International Society for CNS Clinical Trial Methodology. He chaired the Scientific Advisory Board for the National Alliance on Mentally Illness and served as Co-editor-in-chief of the Clinical Approaches to Bipolar Disorder as well as the editorial boards of Current Psychiatry, Medscape and the Psychotic Disorders Review, among others. He has authored over 200 articles, abstracts, books, reviews, and book chapters.
Dr. Sachs has received many awards, among them the Thouron Scholarship, Laughlin Fellowship, Dunlop Award for psychiatric research and writing, a Dupont-Warren Fellowship at the Harvard Medical School and the Massachusetts Psychiatric Association Research Award. He is a distinguished fellow of the American Psychiatric Association and is recognized as a “Top Doctor” by US News and World Report, and by Reuters as among the world’s 100 most influential Psychiatrists, Neurologists and Neuroscientists.
As a recipient of an NIH Small Business Innovative Research Grant, he founded Concordant Rater Systems and holds patents for methods to improve endpoint reliability in clinical trials. He currently focuses his work on clinical trial methodology, innovative approaches to clinical practice and patient-centered research.